Skip to main content
Premium Trial:

Request an Annual Quote

Andre Hoekema, Paul Grint, Scott Kahn, Scott Greer


Galapagos Genomics said last week that it has appointed Andre Hoekema as managing director of Galadeno, the company's viral-based discovery and validation business unit.

Hoekema joins Galadeno from Invitrogen, where he was managing director of corporate development Europe. He has also held positions at Molecular Probes Europe, Crucell, DSM Life Sciences, and Genentech. He holds a PhD in physics and mathematics from Leiden University.

Illumina has appointed Paul Grint to its board of directors. Grint is currently senior vice president and chief medical officer of Zephyr Sciences, a biopharmaceutical company. He received his MD from the University of London, St. Bartholomew's Hospital Medical College.

In addition, Illumina said that Scott Kahn has been appointed Vice President and Chief Information Officer. Kahn joins Illumina from Accelrys, where he served as Chief Scientific Officer. Kahn has previously held positions with BioCAD and Molecular Simulations. He has a PhD in theoretical organic chemistry from the University of California, Irvine, and a post doc from Cambridge University, UK. He is a former assistant professor of chemistry at the University of Illinois, Urbana-Champaign.

Illumina has also announced the April 12 resignation of director Scott Greer, an Illumina director since May 2001. Greer is chairman of Abgenics.

The Scan

Vaccine Update Recommended

A US Food and Drug Administration panel recommends booster vaccines be updated to target Omicron, CNBC reports.

US to Make More Vaccines for Monkeypox Available

The US is to make nearly 300,000 vaccine doses available in the coming weeks to stem the spread of human monkeypox virus, according to NPR.

Sentence Appealed

The Associated Press reports that Swedish prosecutors are appealing the sentence given to a surgeon once lauded for transplanting synthetic tracheas but then convicted of causing bodily harm.

Genome Biology Papers on COVID-19 Effector Genes, Virtual ChIP-seq, scDART

In Genome Biology this week: proposed COVID-19 effector genes, method to predict transcription factor binding patterns, and more.